🔬
Pathology
What the Latest Research Reveals
Data last updated: 35 studies cited
How this page is produced
Generated by the ModernDoc Research Monitor from peer-reviewed literature. Every statistic is automatically checked against its cited source and screened for retractions before it is published. This page is AI-generated and has not yet been reviewed by a clinician — it is not medical advice. Read how we build and check these pages.
57-91%
Microvascular thrombosis prevalence in COVID-19 autopsies
— affecting multiple organ systems
KEY FINDINGS
Pulmonary Microthrombi
7.1x
95% CI: OR 7.1 (95% CI: 4.2-12.1)
Source [8]
Cardiac Microthrombi
9.4x
95% CI: OR 9.4 (95% CI: 4.1-21.5)
Source [13]
CNS Microthrombi
10.8x
95% CI: OR 10.8 (95% CI: 3.5-33.2)
Source [23]
Microvascular Thrombosis Mortality
+180%
95% CI: HR 2.8 (95% CI: 1.9-4.1)
Source [2]
THE TIMELINE
Acute Phase
0-14 days
Subacute Phase
14-30 days
Chronic Phase
30-90 days
Long-Term
>90 days
Acute Phase
0-14 days
Peak viral load, neutrophil infiltration
Key Event
Exudative DAD with hyaline membranes
Pulmonary Microthrombi Prevalence
COVID-1957%
Influenza8%
Source: Ackermann et al., NEJM 2020
Cumulative Organ Damage Risk with Reinfection
1 infection+Baseline tissue injury
2 infections+Additive fibrotic changes
3+ infections+Progressive organ damage
“Each infection may cause cumulative tissue damage and accelerate cellular senescence”
THE HOPEFUL HORIZON
- Some pathological changes resolve within 3-6 months in survivors[25]
- Vaccination significantly reduces severe tissue involvement[26]
- Early antiviral therapy may prevent extensive organ damage[27]
- Research into viral persistence mechanisms informs new treatments
SOURCES
- [1]Wichmann D, Sperhake JP, Lutgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268-277. DOI (opens in new tab)
- [2]Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77(2):198-209. DOI (opens in new tab)
- [3]Lax SF, Sber K, Gellen J, et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med. 2020;173(5):350-361. DOI (opens in new tab)
- [4]Edler C, Schroder AS, Aepfelbacher M, et al. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med. 2020;134(4):1275-1284. DOI (opens in new tab)
- [5]Elezkurtaj S, Greuel S, Ihlow J, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep. 2021;11(1):4263. DOI (opens in new tab)
See a problem with the Pathology research summary?
Send a source correction or freshness concern. We cannot provide personal medical advice through this site.
Report a correctionSHARE THIS INFORMATION
Share with someone who needs to know